PL370367A1 - Antagoniści V receptora CCR-3 - Google Patents

Antagoniści V receptora CCR-3

Info

Publication number
PL370367A1
PL370367A1 PL02370367A PL37036702A PL370367A1 PL 370367 A1 PL370367 A1 PL 370367A1 PL 02370367 A PL02370367 A PL 02370367A PL 37036702 A PL37036702 A PL 37036702A PL 370367 A1 PL370367 A1 PL 370367A1
Authority
PL
Poland
Prior art keywords
ccr
receptor antagonists
antagonists
receptor
Prior art date
Application number
PL02370367A
Other languages
English (en)
Inventor
Bois Daisy Joe Du
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL370367A1 publication Critical patent/PL370367A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/41Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02370367A 2001-09-13 2002-09-05 Antagoniści V receptora CCR-3 PL370367A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31899201P 2001-09-13 2001-09-13

Publications (1)

Publication Number Publication Date
PL370367A1 true PL370367A1 (pl) 2005-05-16

Family

ID=23240431

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370367A PL370367A1 (pl) 2001-09-13 2002-09-05 Antagoniści V receptora CCR-3

Country Status (12)

Country Link
US (2) US7049317B2 (pl)
EP (1) EP1427696A1 (pl)
JP (1) JP2005502700A (pl)
KR (1) KR100652451B1 (pl)
CN (1) CN1267412C (pl)
AR (1) AR036508A1 (pl)
BR (1) BR0212451A (pl)
CA (1) CA2459364A1 (pl)
MX (1) MXPA04001977A (pl)
PL (1) PL370367A1 (pl)
RU (1) RU2286339C2 (pl)
WO (1) WO2003022799A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291615B2 (en) 2003-05-01 2007-11-06 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
IN2006CH00378A (en) * 2003-06-30 2007-05-11 Sumitomo Chemical Co Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
US7378409B2 (en) * 2003-08-21 2008-05-27 Bristol-Myers Squibb Company Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
WO2007034252A1 (en) * 2005-09-22 2007-03-29 Sanofi-Aventis Amino-alkyl-amide derivatives as ccr3 receptor liquids
HUP0500879A2 (en) 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098904A (en) * 1976-11-12 1978-07-04 The Upjohn Company Analgesic n-(2-aminocycloaliphatic)benzamides
US4204003A (en) * 1976-11-30 1980-05-20 The Upjohn Company N-(2-Aminocyclopentyl)-N-alkanoylanilides as CNS anti-depressants
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
CA2157412A1 (en) 1993-03-03 1994-09-15 Julia Marie Heerding Balanoids
DE4326344A1 (de) 1993-08-05 1995-02-09 Thomae Gmbh Dr K Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
FR2729140A1 (fr) 1995-01-06 1996-07-12 Smithkline Beecham Lab Nouveaux derives d'amine, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu'agents anti-arythmiques
EP1086078B1 (en) 1998-06-08 2003-02-05 Schering Corporation Neuropeptide y5 receptor antagonists
KR20010086045A (ko) * 1998-11-20 2001-09-07 프리돌린 클라우스너, 롤란드 비. 보레르 피롤리딘 유도체-씨씨알-3 수용체 길항제
US6462076B2 (en) * 2000-06-14 2002-10-08 Hoffmann-La Roche Inc. Beta-amino acid nitrile derivatives as cathepsin K inhibitors
EP1343751A2 (en) * 2000-12-20 2003-09-17 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
US6576792B2 (en) * 2001-05-04 2003-06-10 Eastman Kodak Company 2-halo-1-cycloalkenecarboxamides and their preparation
US7291744B2 (en) * 2003-11-13 2007-11-06 Bristol-Myers Squibb Company N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
CA2459364A1 (en) 2003-03-20
MXPA04001977A (es) 2004-06-07
RU2286339C2 (ru) 2006-10-27
US20060167105A1 (en) 2006-07-27
AR036508A1 (es) 2004-09-15
CN1267412C (zh) 2006-08-02
BR0212451A (pt) 2004-10-19
RU2004111535A (ru) 2005-10-20
EP1427696A1 (en) 2004-06-16
US7049317B2 (en) 2006-05-23
US20030119885A1 (en) 2003-06-26
WO2003022799A1 (en) 2003-03-20
KR100652451B1 (ko) 2006-12-01
JP2005502700A (ja) 2005-01-27
KR20040044915A (ko) 2004-05-31
CN1555358A (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
GB2343891B (en) 4-Aroyl-piperidine CCR-3 receptor antagonists
EP1351933A4 (en) ANTAGONISTS OF IL-8 RECEPTORS
IL152775A0 (en) Il-8 receptor antagonists
GB9927228D0 (en) CCR-3 receptor antagonists II
DZ3309A1 (en) Il-8 receptor antagonists
PL378753A1 (pl) Antagoniści receptora CCR-3
HK1063791A1 (en) Nk1 antagonists
IL151431A0 (en) Il-8 receptor antagonists
EP1359915A4 (en) UROTENSIN-II RECEPTOR ANTAGONISTS
EP1274415A4 (en) IL-8 RECEPTOR ANTAGONISTS
PL362838A1 (pl) Antagoniści somatostatyny
IL151210A0 (en) Il-8 receptor antagonists
EP1265905A4 (en) IL-2 RECEPTOR ANTAGONISTS
AU2003240705A1 (en) Morpholinylmethylureas ccr-3 receptor antagonists
EP1351687A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
HK1047750A1 (zh) 趨化因子受體拮抗劑
EP1274413A4 (en) IL-8 RECEPTOR ANTAGONISTS
PL370367A1 (pl) Antagoniści V receptora CCR-3
PL373275A1 (pl) Antagoniści VII receptora CCR-3
EP1263427A4 (en) ANTAGONISTS OF THE INTERLEUKIN 8 RECEPTOR
EP1274428A4 (en) INTERLEUKIN-8 (IL-8) RECEPTOR ANTAGONISTS
PL370821A1 (pl) N-Ureidopiperydyny jako antagoniści VIII receptora CCR-3
IL156087A0 (en) Histamine receptor antagonists
EP1261329A4 (en) IL-8 RECEPTOR ANTAGONISTS
IL158063A0 (en) Crf receptor antagonists

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)